![](/img/cover-not-exists.png)
PCN21 FIRST-LINE BEVACIZUMAB-BASED THERAPY VERSUS PEMETREXED + CISPLATIN FOR THE TREATMENT OF ADVANCED ADENOCARCINOMA NONSQUAMOUS NON-SMALL CELL LUNG CANCER: INDIRECT COMPARISON APPLYING REAL-LIFE OUTCOMES
K Berenson, C Chouaid, A Vergnenegre, S Sherman, S WalzerVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71918-0
File:
PDF, 78 KB
english, 2010